Evaluation of Vitek2 and BD Phoenix in antimicrobial susceptibility testing of Acinetobacter baumannii and Pseudomonas aeruginosa

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The accuracy of antimicrobial susceptibility testing of Vitek2 and BD Phoenix against Acinetobacter baumannii and Pseudomonas aeruginosa was evaluated. Both systems showed overall categoric agreement of ≤90% for cefepime and ceftazidime against A. baumannii and imipenem and cefepime (and ceftazidime with Vitek2) against P. aeruginosa because of high minor error rates.

Original languageEnglish
Pages (from-to)384-386
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume67
Issue number4
DOIs
StatePublished - Aug 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acinetobacter baumannii
  • BD Phoenix
  • Pseudomonas aeruginosa
  • Vitek2

Fingerprint

Dive into the research topics of 'Evaluation of Vitek2 and BD Phoenix in antimicrobial susceptibility testing of Acinetobacter baumannii and Pseudomonas aeruginosa'. Together they form a unique fingerprint.

Cite this